Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Survival motor neuron 2 protein is an essential component for RNA processing machinery integrity and neuronal health. Its deficiency underlies spinal muscular atrophy due to impaired pre-mRNA splicing machinery assembly—a defect that can be therapeutically targeted by modulating alternative splicing from its encoding gene (*SMN2*).
Enhances correct splicing from *SMN2*, increasing production of functional full-length SMN protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Survival motor neuron 2 protein (SMN2).